News, events, and resources
Jan 12, 2026
New Head of West Coast business development at CBS, Allan Cortes!
Allan Cortes joins CBS as Head of West Coast business development, bringing unparalleled experience in biotech and CRO business development.
Dec 22, 2025
Meet Us at WCBP 2026: All Symposium Details Included
Crystal Bio Solution is attending as exhibitor at WCBP 2026. What is WCBP, who should attend, and why it matters for CMC and biologics.
Dec 15, 2025
Sterility Assays in Drug and Device Manufacturing
Sterility and endotoxin assays are essential GMP tests ensuring drug and device safety, regulatory compliance, and reliable release across ...
Dec 15, 2025
Critical Quality Attribute D0 Impact in ADC Modality
Overview of D0 species in ADCs, compete for target binding, reduce ADC potency, and how they are characterized analytically in development.
Dec 15, 2025
Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality
Overview of ADC components and related CQAs, highlighting how antibody, linker, and payload heterogeneity affect potency, stability and ...
Nov 21, 2025
Strategies for Antibody-Drug Conjugates Bioanalysis
Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ...
Oct 9, 2025
Improving the Sensitivity and Drug Tolerance of a NAb Assay by Optimizing MRD
Optimizing the Minimal Required Dilution (MRD) in a cLBA NAb assay improved sensitivity fourfold and drug tolerance fivefold, enhancing ...
Sep 18, 2025
Representative Pooled Matrix Selection is Critical in ADA Assays
Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays
Sep 18, 2025
A Generic LC-MS/MS Solution for ADC PK Bioanalysis
Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ...
Sep 18, 2025
An immunogenicity analysis strategy to reduce the interference of soluble target proteins
Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ...
New Head of West Coast business development at CBS, Allan Cortes!
Allan Cortes joins CBS as Head of West Coast business development, bringing unparalleled experience in biotech and CRO business development.
Meet Us at WCBP 2026: All Symposium Details Included
Crystal Bio Solution is attending as exhibitor at WCBP 2026. What is WCBP, who should attend, and why it matters for CMC and biologics.
Sterility Assays in Drug and Device Manufacturing
Sterility and endotoxin assays are essential GMP tests ensuring drug and device safety, regulatory compliance, and reliable release across ...
Critical Quality Attribute D0 Impact in ADC Modality
Overview of D0 species in ADCs, compete for target binding, reduce ADC potency, and how they are characterized analytically in development.
Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality
Overview of ADC components and related CQAs, highlighting how antibody, linker, and payload heterogeneity affect potency, stability and ...
Strategies for Antibody-Drug Conjugates Bioanalysis
Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ...
Improving the Sensitivity and Drug Tolerance of a NAb Assay by Optimizing MRD
Optimizing the Minimal Required Dilution (MRD) in a cLBA NAb assay improved sensitivity fourfold and drug tolerance fivefold, enhancing ...
Representative Pooled Matrix Selection is Critical in ADA Assays
Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays
A Generic LC-MS/MS Solution for ADC PK Bioanalysis
Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ...
An immunogenicity analysis strategy to reduce the interference of soluble target proteins
Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ...
